27.02.2024 13:04:30 - dpa-AFX: *LIGAND PHARMA Q4 CORE ADJ. NET INCOME RISES TO $18.6 MLN OR $1.05/SHR FROM $13.0 MLN OR $0.75/SHR LAST YEAR

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Ligand Pharmaceuticals A1C9RN NASDAQ 97,260 15.07.24 20:57:11 -2,150 -2,16% 97,260 97,750 100,000 99,410

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH